By Kevin E. Noonan — Trial courts tend to get more than the benefit of the doubt when their decisions are viewed under the “abuse of discretion” standard, and juries similarly are affirmed unless there isn’t substantial evidence supporting their verdicts. Both these rubrics, which extend more generally to cases involving disputes outside patent law, were used by the Federal Circuit to affirm both the finding of infringement and a hefty ($89,712,069) damages calculation in Vectura Ltd. v. GlaxoSmithKline LLC. The case arose involving Vectura’s patented components for pulmonary administration for dry-powder inhalers, the components claimed in U.S. Patent No….
